News
Amid restructuring, the agency is likely to gut its research program for evaluating the health risks of toxic chemicals.
In "More Everything Forever," Adam Becker unpacks the flaws in the dreams of tech pioneers to reshape the world to come.
Trump’s executive orders are affecting how federally funded journals operate. Some researchers have raised alarms.
Tensions over food stamp restrictions are bubbling between the soda industry and the Trump administration, splitting Republicans and driving a lobbying bonanza. Health advocates and some states have ...
Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.
In “The Age of Diagnosis,” Suzanne O’Sullivan challenges some common assumptions about how we detect and treat disease.
Even critics of the global health organization say that the United States' withdrawal won’t solve pressing problems.
RFK Jr. shifted $500 million from a pandemic preparedness fund to a single nascent flu vaccine development program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results